Energy & Critical Infrastructure
Defending national critical assets against geopolitical cyber threats. Specialized governance for energy, utilities, and essential service providers.
Read further
Critical Infrastructure Sector
Protecting the intellectual property that drives medical innovation. We secure R&D data, clinical trial integrity, and manufacturing compliance.
Theft of R&D and patent data
Clinical trial data integrity attacks
Regulatory fines (GDPR/HIPAA/NIS2)
Industrial espionage
Biomanufacturing supply chain risks
In the pharmaceutical and biotech sectors, the molecule is the asset. Years of R&D, clinical trials, and billions in capital expenditure can be exfiltrated in seconds by a state-sponsored actor or a competitor's insider. Intarmour protects the entire lifecycle of medical innovation, from the initial bench research to the final FDA approval and market exit.
We understand that in this industry, a data breach is not just an IT incident; it is a forfeiture of exclusivity. If your IP leaks, your valuation collapses. We provide the containment architecture necessary to keep your proprietary formulas and trial data strictly within your control.
IP Protection & Anti-Espionage For biotech startups and established pharma giants, the primary threat is industrial espionage. We implement rigorous "Data Loss Prevention" (DLP) strategies and sovereign storage solutions. We ensure that your formulas, molecular structures, and patient data never leave your designated perimeter. We treat your server room with the same security protocols as your Level-4 Biosafety Lab.
Clinical Trial Integrity Regulators (EMA, FDA) demand absolute data integrity. A cyber compromise that alters clinical trial data - even by a fraction - can invalidate years of research and destroy a drug's path to market. We validate the immutability of your research data using blockchain-style verification and sovereign custody, ensuring that your results are defensible during regulatory audits.
M&A Readiness Biotech is an industry driven by acquisition. A history of lax security can devalue a startup immediately during the Due Diligence phase. We prepare your security posture to withstand the rigorous technical scrutiny of Big Pharma acquirers, ensuring your exit value remains intact.
Research Security Architecture
Compliance & GxP Governance
Value Preservation We understand that your company's valuation is tied 100% to your IP. Our security strategy has one singular goal: preserving the exclusivity of that IP.
Sovereign Storage We offer neutral, Swiss-hosted storage for sensitive trial data, protecting it from jurisdictional overreach (such as the US CLOUD Act) and competitor surveillance.
Secure your research from the lab bench to the bedside. Do not let espionage erase your innovation.
Secure Your IP: Contact us to discuss an Intellectual Property defense strategy. We can secure your core assets within 48 hours.
We understand the unique kinetic and digital risks faced by Pharmaceuticals & Biotech entities. We provide sovereign defense architectures tailored to sector-specific regulatory and operational requirements.
+ M&A Cyber Due Diligence
+ Fractional CISO
+ Sovereign Comms & VDR
+ Supply Chain Risk Management
Other high-stakes environments secured by Intarmour sovereign protocols.
Transform security from a technical hurdle into a strategic advantage. Protect your deal flow, your IP, and your reputation with the industry leaders.